Advanced Filters
noise
Found 1,274 clinical trials
B Brittany McCrory, BS

Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents

This study is dedicated to help identify biomarkers for depression and suicide. The purpose of the study is to better understand these links to improve medical and psychiatric care in the future. This research is also to test the effects of standard treatment of depression on improvement in depressive and …

10 - 24 years of age All Phase N/A
J Jakob Näslund, MD, PhD

OSU6162 as add-on in SSRI/SNRI-resistant Depression

This is a randomised, placebo-controlled, parallel-group trial comparing OSU6162 at flexible dosage with placebo as add-on to treatment with an SSRI/SNRI in patients with depression that have not responded to treatment with an SSRI/SNRI per se for at least 6 weeks. The study will last for 6 weeks, after which …

25 - 65 years of age All Phase 2
F Fan-Ko Sun, PhD

The Effects of Logotherapy in Adolescents With Mood Disorders

Logotherapy can help people find their meaning in life and help people reduce their suicidal ideation. Suicide was the second leading cause of death for 15-24 year-olds. Logotherapy can increase exploration of meaning in life for adolescents and prevent them from attempting suicide. However, most research only explored the effects …

15 - 24 years of age All Phase N/A
J Jay C Buckey, M.D.

Internet Based Psychological Support

The investigators have developed interactive, multimedia-intensive, computer-based treatment programs that include depression (Problem-Solving Therapy), stress management, and conflict management. Together the three modules are called PATH. The problem-solving module is based on an evidence-based psychotherapy called Problem-Solving Therapy in which depressed patients identify problems in their lives and work through …

18 years of age All Phase N/A

Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation

The purpose of this study is to gather information regarding the use of a new type of transcranial magnetic stimulation (TMS) called theta burst stimulation (TBS) for suicidal ideation in adolescents with Major Depressive Disorder (MDD). The investigators hope to learn if this TMS treatment improves suicidal ideation over 10 …

12 - 18 years of age All Phase N/A
M Margo Nathan

Depression, Aging, Stress and Heart Health Study

Depression is a known risk factor for cardiovascular disease (CVD), and this comorbidity contributes significantly to the morbidity and mortality of women. The menopausal transition or perimenopause is a period of vulnerability for both depression and CVD, making it a key time to study this critical public health issue. This …

44 - 55 years of age Female Phase N/A
J Jo Anne Sirey, PhD

Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation

The purpose of this randomized trial is to conduct a fully powered effectiveness trial of video-delivered PROTECT (Tele-PROTECT) compared to a video-delivered depression education (DepEd) control condition to be delivered to 140 English- and Spanish-speaking NYC elder abuse victims. Investigators hypothesize three main aims: Effectiveness Aim: Tele-PROTECT participants will have …

60 years of age All Phase N/A
C Carlos Zarate, M.D.

Neurobiology of Suicide

Background There are no good treatments for people considering suicide. Researchers want to study suicide with questions, blood tests, brain imaging, and sleep studies. They hope to better understand suicide, so they can help suicidal people. Objective To understand what happens in the brain when someone has thought about or …

18 - 70 years of age All Phase 2
R Rodrigo B Mansur, M.D.

Brain Insulin Resistance in Mood Disorders

The overarching aim of the study is to determine the role of insulin signaling on the neurobiological substrates subserving anhedonia within individuals with mood disorders (i.e., Bipolar Disorder (BD) and Major Depressive Disorder (MDD)). Specific aims include: Molecular: Assessment of components of the insulin cascade, as well as of anhedonia …

18 - 60 years of age All Phase 1/2
A Asem Bala, MSc

Neurocognitive Effects of FMT in MDD Patients With and Without IBS

This study is a phase 2/3 open-label controlled trial (CT) in which adults with Major Depressive Disorder (MDD) and adults who have MDD plus comorbid Inflammatory Bowel Syndrome (IBS) will be assigned to either receive oral Fecal Microbiota Transplantation (FMT) or to continue with the treatment they are currently receiving …

18 - 60 years of age All Phase 2/3

Simplify language using AI